相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer
Barry H. Trachtenberg et al.
PEDIATRIC CARDIOLOGY (2011)
The use of B-type natriuretic peptide in paediatric patients: a review of literature
Silvia Favilli et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2009)
Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
Gabriella Mariani et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group n9831 adjuvant breast cancer trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
Thomas M. Suter et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31
E Tan-Chiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Theoretical and empirical derivation of cardiovascular allometric relationships in children
T Sluysmans et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma
K Scotlandi et al.
EUROPEAN JOURNAL OF CANCER (2005)
Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas
JK Anninga et al.
EUROPEAN JOURNAL OF CANCER (2004)
Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma
DPM Hughes et al.
CANCER RESEARCH (2004)
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia
SE Lipshultz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Evaluation of the predictive value of Her-2/neu gene expression on osteosarcoma therapy in laser-microdissected paraffin-embedded tissue
J Fellenberg et al.
LABORATORY INVESTIGATION (2004)
Primary metastatic osteosarcoma:: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
HER-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification
H Zhou et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
ErbB2 expression is correlated with increased survival of patients with osteosarcoma
T Akatsuka et al.
CANCER (2002)
Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma
SE Kilpatrick et al.
MODERN PATHOLOGY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)